A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS)
Clinical trial NCT07074886 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07074886
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-13
- Primary completion
- 2026-09-17
- Enrollment
- 193
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.